retatrutide

Retatrutide is an experimental medication that targets obesity and metabolic disorders by activating GLP-1, GIP, and glucagon receptors.

It reduces appetite, improves blood sugar control, and leads to major fat loss while preserving muscle. It also supports better cholesterol levels, lowers blood pressure, and reduces inflammation.

Retatrutide can help reduce fat in the liver, making it promising for treating or preventing fatty liver disease (NAFLD). Early research also suggests it may reduce addictive behaviors like cravings for food, alcohol, or other substances — possibly by affecting brain reward pathways.

It slightly boosts metabolism and often improves mood, energy, and motivation. Overall, retatrutide offers powerful benefits for weight loss, liver health, and addiction control.